AU2002226004A1 - Use of factor xiii for treating hemophilia b - Google Patents

Use of factor xiii for treating hemophilia b

Info

Publication number
AU2002226004A1
AU2002226004A1 AU2002226004A AU2600402A AU2002226004A1 AU 2002226004 A1 AU2002226004 A1 AU 2002226004A1 AU 2002226004 A AU2002226004 A AU 2002226004A AU 2600402 A AU2600402 A AU 2600402A AU 2002226004 A1 AU2002226004 A1 AU 2002226004A1
Authority
AU
Australia
Prior art keywords
factor xiii
treating hemophilia
hemophilia
factor
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002226004A
Inventor
Paul D. Bishop
Jan Ohrstrom
Lynn M. Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2002226004A1 publication Critical patent/AU2002226004A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Use of factor XIII for treating hemophilia B. A patient having hemophilia B is treated by administering factor XIII generally in conjunction with factor IX.
AU2002226004A 2000-11-10 2001-11-08 Use of factor xiii for treating hemophilia b Abandoned AU2002226004A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24736200P 2000-11-10 2000-11-10
US60/247,362 2000-11-10
PCT/US2001/047144 WO2002038167A2 (en) 2000-11-10 2001-11-08 Use of factor xiii for treating hemophilia b

Publications (1)

Publication Number Publication Date
AU2002226004A1 true AU2002226004A1 (en) 2002-05-21

Family

ID=22934628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226004A Abandoned AU2002226004A1 (en) 2000-11-10 2001-11-08 Use of factor xiii for treating hemophilia b

Country Status (8)

Country Link
EP (1) EP1351706B1 (en)
JP (1) JP2004513150A (en)
AT (1) ATE367824T1 (en)
AU (1) AU2002226004A1 (en)
CA (1) CA2429018A1 (en)
DE (1) DE60129599T2 (en)
ES (1) ES2288524T3 (en)
WO (1) WO2002038167A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080176789A1 (en) 2004-08-27 2008-07-24 Novc Nordisk Healthcare A/G Purification of Factor Xlll Polypeptides From Biological Materials
JP5086093B2 (en) 2004-11-23 2012-11-28 ジモジェネティクス、インコーポレイテッド Purification of recombinant human factor XIII

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001512A1 (en) * 1987-08-17 1989-02-23 The Liposome Company, Inc. A sponge enzyme having transglutaminase-like activity
WO2001085198A1 (en) * 2000-05-10 2001-11-15 Novo Nordisk A/S tHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIA AND A FACTOR XIII

Also Published As

Publication number Publication date
DE60129599D1 (en) 2007-09-06
ATE367824T1 (en) 2007-08-15
EP1351706A2 (en) 2003-10-15
JP2004513150A (en) 2004-04-30
ES2288524T3 (en) 2008-01-16
DE60129599T2 (en) 2008-04-17
CA2429018A1 (en) 2002-05-16
EP1351706B1 (en) 2007-07-25
WO2002038167A2 (en) 2002-05-16
WO2002038167A3 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
DE60115842D1 (en) VALVE ARRANGEMENT
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
TW200505434A (en) Therapeutic treatment
SE9701162D0 (en) New use II
HK1068811A1 (en) Substituted oxazolidinones for combinational therapy
AU1249902A (en) Effective antitumour treatments
MY164077A (en) Compositions and uses of et743 for treating cancer
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
HK1029932A1 (en) Use of mirtazapine for the manufacture of a medicament for treating sleep apneas.
IL150125A0 (en) Novel compounds
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
GB0020504D0 (en) Therapeutic method
AU2002226004A1 (en) Use of factor xiii for treating hemophilia b
AU3885799A (en) Antidepressant therapy
IL159770A0 (en) Calcium salts with cytotoxic activity
AU2002225994A1 (en) Use of blood coagulation factor xiii for treating haemophilia
NZ528064A (en) Utilization of buprenorphine in urinary incontinence therapy
NZ334660A (en) use of sulodexide to treat diabetic retinopathy
AU7768601A (en) Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
DE60234995D1 (en) TATA CANCER
DE60316927D1 (en) USE OF DEVAZEPIDE AS PAIN
MXPA03000959A (en) Combinations of dalfopristine/quinupristine with cefpirome.
IL161189A (en) Use of factor xiii for preparation of a medicament for inhibiting the formation of seromas
UA36666A (en) method for treatment of the chronic gastritis gastriti, Associated with Helicobacter infection